Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05026723 · ClinicalTrials.gov registry record · NA

Food as Medicine for HIV and Diabetes

A NA study of HIV Infections and Diabetes Mellitus, Type 2, sponsored by University of North Carolina, Chapel Hill.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT05026723 is a NA study of HIV Infections and Diabetes Mellitus, Type 2 that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 200 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05026723, a NA study of HIV Infections and Diabetes Mellitus, Type 2, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

This is a single-site, open-label, Phase II, community-based randomized controlled explanatory trial to test the efficacy of a medically tailored meal + intensive lifestyle intervention (MTM + ILI) intervention for adults with food insecurity, HIV, and T2DM or high risk of T2DM, compared with a group that receives usual MTM.

Conditions Studied

HIV Infections Diabetes Mellitus, Type 2 PreDiabetes

Interventions

  • BEHAVIORAL MTM + ILI
  • BEHAVIORAL Standard MTM

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2021-10-04
Est. Completion 2027-02
Phase NA

Sponsor

University of North Carolina, Chapel Hill

1,109 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05026723

The ClinicalTrials.gov registry entry for NCT05026723 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (55% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which MTM + ILI is the first listed.

NCT05026723 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05026723 about?

NCT05026723 is a clinical study titled "Food as Medicine for HIV and Diabetes". This is a single-site, open-label, Phase II, community-based randomized controlled explanatory trial to test the efficacy of a medically tailored meal + intensive lifestyle intervention (MTM + ILI) intervention for adults with food insecurity, HIV, and T2DM or high risk of T2DM, compared with a grou...

What is the current status of trial NCT05026723?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2021-10-04. Estimated completion is 2027-02.

What conditions does trial NCT05026723 study?

This clinical trial studies the following conditions: HIV Infections, Diabetes Mellitus, Type 2, PreDiabetes.

What interventions are being tested in trial NCT05026723?

The interventions under investigation include: MTM + ILI (BEHAVIORAL), Standard MTM (BEHAVIORAL).

Who is sponsoring clinical trial NCT05026723?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05026723 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Diabetes Mellitus, Type 2

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.